On Invalid Date, Nautilus Biotechnology (NASDAQ: NAUT) reported Q3 2023 earnings per share (EPS) of -$0.13, up 18.18% year over year. Total Nautilus Biotechnology earnings for the quarter were -$15.88 million. In the same quarter last year, Nautilus Biotechnology's earnings per share (EPS) was -$0.11.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.